查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1136991

細胞因子市場：按細胞因子類型、治療用途、地區 - 規模、份額、前景、機會分析，2022-2028

Cytokine Market, By Cytokine Type, By Therapeutic Application, and By Geography - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028
出版日期: | 出版商: Coherent Market Insights | 英文 165 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

細胞因子是一類在細胞信號傳導中很重要的小蛋白。一種對調節其他免疫系統細胞和血細胞的生長和活性至關重要的小蛋白質。細胞因子影響所有血細胞和其他有助於身體免疫和炎症反應的細胞的生長。細胞因子是響應入侵病原體而產生的，以刺激、招募和增殖免疫細胞。細胞因子還通過發送信號殺死異常細胞並延長正常細胞的壽命來增強抗癌作用。此外，基於細胞因子的療法可能為癌症、自身免疫性疾病和許多類型的傳染病提供新的治療方法。

市場動態

癌症治療的廣泛接受度、細胞因子作為新生兒敗血症潛在生物標誌物的使用增加、幹細胞治療的潛在貢獻以及 COVID-19 的爆發預計將有助於增長全球細胞因子市場。是一些關鍵因素那

細胞因子是分子信使，使免疫系統的細胞能夠相互交流，並引發對目標抗原的協調、強大但自限性的反應。有兩種類型的細胞因子用於治療癌症患者：干擾素 (INF) 和白細胞介素 (IL)。因此，隨著癌症患病率的增加，細胞因子在癌症治療中的應用也在增加。

例如，根據 GLOBOCAN 2020 報告，美國約有 2,556,022 人患有癌症，預計到 2035 年這一數字將達到 3,316,283 人。預計越來越多的癌症患者將推動市場的增長。

本研究的主要特點

  • 本報告對全球細胞因子市場進行了深入分析，提供了以 2021 年為基準年的預測期（2022-2028 年）的市場規模和復合年增長率 (CAGR %)。
  • 它還闡明了各個細分市場的潛在收入機會，並描述了對該市場有吸引力的投資主張矩陣。
  • 它還提供有關市場驅動因素、限制因素、機會、新產品發布或批准、市場趨勢、區域前景、主要參與者採用的競爭策略等方面的重要見解。
  • 基於公司亮點、產品組合、關鍵亮點、經營成果和戰略等參數的全球細胞因子市場主要參與者的概況。
  • 本研究涵蓋的主要公司包括 Biocon Limited、Johnson & Johnson、Abbvie Inc.、UCB S.A.、Astra Zeneca PLC、Sanofi SA、Pfizer Inc.、Novartis International AG、Amgen Inc. 和 GlaxoSmithKline PLC，其中其他。
  • 本報告中的見解將使營銷人員和企業高管能夠就未來的產品發布、類型升級、市場擴張和營銷策略做出明智的決策。.
  • 全球細胞因子市場報告迎合了該行業的各種利益相關者，包括投資者、供應商、產品製造商、分銷商、新進入者和金融分析師。
  • 利益相關者通過用於分析全球細胞因子市場的各種戰略矩陣來促進決策制定。

內容

第 1 章目的和先決條件

  • 調查目的
  • 先決條件
  • 縮寫說明

第二章市場展望

  • 舉報內容
    • 市場定義和範圍
  • 執行摘要
    • 市場快照：按細胞因子類型
    • 市場快照：按治療應用
    • 市場概況：按地區劃分
  • 連貫的機會圖 (COM)

第 3 章市場動態、監管和趨勢分析

  • 市場動態
    • 全球癌症發病率上升
    • 細胞因子治療費用高
    • 增加細胞因子的診斷和治療應用
  • 影響分析
  • 主要亮點
  • 監管場景
  • 產品發布/批准
  • PEST 分析
  • PORTER 分析
  • 併購方案

第 4 章全球細胞因子市場 - 冠狀病毒 (COVID-19) 大流行的影響

  • COVID-19 的流行病學特徵
  • 供應方和需求方分析
  • 經濟影響

第 5 章全球細胞因子市場，按細胞因子類型，2017-2028 年

  • 腫瘤壞死因子-TNF
  • 白介素-IL
  • 干擾素-IFN
  • 表皮生長因子-EGF
  • 其他細胞因子類型

第 6 章全球細胞因子市場，按治療用途，2017-2028 年

  • 癌症
  • 支氣管哮喘和氣道炎症
  • 關節炎
  • 其他治療用途

第 7 章全球細胞因子市場，按地區分列，2017-2028 年

  • 北美
  • 歐洲
  • 亞太地區
  • 拉丁美洲
  • 中東和非洲
  • 世界其他地區

第 8 章競爭格局

  • Biocon Limited
  • Johnson & Johnson
  • Abbvie Inc.
  • UCB S.A.
  • Astra Zeneca PLC
  • Sanofi SA
  • Pfizer Inc.
  • Novartis International AG
  • Amgen Inc.
  • GlaxoSmithKline PLC

第九章章節

  • 調查方法
  • 關於出版商
簡介目錄
Product Code: CMI5238

Cytokines are a category of small proteins important in cell signaling. They are small proteins that are crucial in controlling the growth and activity of other immune system cells and blood cells. Cytokines affect the growth of all blood cells and other cells that help the body's immune and inflammation responses. They are produced in response to invading pathogens to stimulate, recruit, and proliferate immune cells. Cytokines also help boost anti-cancer activity by sending signals that can help make abnormal cells die and normal cells live longer. Moreover, cytokine-based therapies have the potential to provide novel treatments for cancer, autoimmune diseases, and many types of infectious disease.

Market Dynamics:

Increased acceptance in cancer therapy, increase in use of cytokine as a potential biomarker for neonatal sepsis, potential contribution in stem cell therapy, and the outbreak of COVID-19 are some major factors expected to aid in the growth of the global cytokine market.

Cytokines are molecular messengers that allow the cells of the immune system to communicate with one another, to generate a coordinated, robust, but self-limited response to a target antigen. There are two types of cytokines used to treat patients with cancer, such as interferons (INFs) and interleukins (ILs). Thus, with the increase in prevalence of cancer, the adoption of cytokine in cancer therapy is also increasing.

For instance, as per the report from GLOBOCAN 2020, around 2,556,022 people in the United States were affected with cancer and this number is expected to reach 3,316,283 by 2035. The rise in cancer cases is expected to boost the growth of the market.

Key features of the study:

  • This report provides in-depth analysis of the global cytokine market, and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2022-2028), considering 2021 as the base year.
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
  • It profiles key players in the global cytokine market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
  • Key companies covered as a part of this study include Biocon Limited, Johnson & Johnson, Abbvie Inc., UCB S.A., Astra Zeneca PLC, Sanofi SA, Pfizer Inc., Novartis International AG, Amgen Inc., and GlaxoSmithKline PLC, among others.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
  • The global cytokine market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global cytokine market.

Detailed Segmentation:

  • Global Cytokine Market, By Cytokine Type:
    • Tumor Necrosis Factor-TN
    • Interleukins-IL
    • Interferons-IFN
    • Epidermal Growth Factor-EGF
    • Other Cytokine Types
  • Global Cytokine Market, By Therapeutic Application:
    • Cancer
    • Asthma and Airway Inflammation
    • Arthritis
    • Other Therapeutic Applications
  • Global Cytokine Market, By Geography:
    • North America
    • Europe
    • Asia-Pacific
    • Middle East and Africa
    • South America
  • Company Profiles:
    • Biocon Limited
    • Johnson & Johnson,
    • Abbvie Inc.
    • UCB S.A.
    • Astra Zeneca PLC
    • Sanofi SA
    • Pfizer Inc.
    • Novartis International AG
    • Amgen Inc.
    • GlaxoSmithKline PLC

Table of Contents:

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snapshot, By Cytokine Type
    • Market Snapshot, By Therapeutic Application
    • Market Snapshot, By Geography
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Increase in burden of cancer around the world
    • High cost of cytokines-based therapies
    • Rising number of diagnostic and therapeutic applications of cytokines
  • Impact Analysis
  • Key Highlights
  • Regulatory Scenario
  • Product launch/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Merger and Acquisition Scenario

4. Global Cytokine Market - Impact of Coronavirus (COVID-19) Pandemic

  • COVID-19 Epidemiology
  • Supply Side and Demand Side Analysis
  • Economic Impact

5. Global Cytokine Market, By Cytokine Type, 2017-2028, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2022 and 2028 (%)
    • Y-o-Y Growth Analysis, 2017 - 2028
    • Segment Trends
  • Tumor Necrosis Factor-TNF
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
  • Interleukins-IL
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
  • Interferons-IFN
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
  • Epidermal Growth Factor-EGF
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
  • Other Cytokine Types
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)

6. Global Cytokine Market, By Therapeutic Application, 2017-2028, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2022 and 2028 (%)
    • Y-o-Y Growth Analysis, 2017 - 2028
    • Segment Trends
  • Cancer
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
  • Asthma and Airway Inflammation
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
  • Arthritis
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
  • Other Therapeutic Applications
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)

7. Global Cytokine Market, By Geography, 2017-2028, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2022 and 2028 (%)
    • Y-o-Y Growth Analysis, 2017 - 2028
    • Segment Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2028,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2028,(US$ Mn)
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2028,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2028,(US$ Mn)
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2028,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2028,(US$ Mn)
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2028,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2028,(US$ Mn)
  • Middle East and Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2028,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2028,(US$ Mn)
  • Rest of World
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2028,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2028,(US$ Mn)

8. Competitive Landscape

  • Biocon Limited
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Johnson & Johnson
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Abbvie Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • UCB S.A.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Astra Zeneca PLC
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Sanofi SA
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Pfizer Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Novartis International AG
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Amgen Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • GlaxoSmithKline PLC
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Analyst Views

9. Section

  • Research Methodology
  • About us